DIREVO Industrial Biotechnology GmbH appoints Dr. Joerg Riesmeier as COO
DIREVO Industrial biotechnology GmbH (DIREVO) announced the appointment of Dr. Joerg Riesmeier as Managing Director and Chief Operating Officer with immediate effect. Dr. Riesmeier is an executive with a proven track record in industrial biotechnology, both in long-range industry investment and in product development. He will be leading the company together with the company’s CEO, Dr. Thomas von Rüden.
Dr. Riesmeier joins DIREVO from LSP, Inc. (Boston), where he had been General Partner since 2006. He launched and directed the US office of this $1 b global venture-capital firm, holding responsibility for $100 m investment portfolio development and management, with a focus on clean technologies, agriculture, platform technologies, food and nutrition, and health.
Prior to his position at LSP, Dr. Riesmeier was Head of Business Development at BURRILL & CO. (San Francisco), where he held responsibility for AgBio and Nutraceutical funds, managing the Bayer account at Burrill and $100 m in venture capital.
Previously, Dr. Riesmeier was President & CEO at PLANTTEC BIOTECHNOLOGY– Potsdam, Germany (acquired by Bayer CropScience), an €8 m biotech startup that he created and supervised, maintaining leadership through acquisition by Bayer CropScience in 2000 and assuming strategic business development and R&D roles within Bayer.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
